Letters to the Editor

Bonnet-Brilhault F Thibaut F Leprieur A Petit M . A case of paroxetine-induced akathisia andareview of SSRI-induced akathisia. Eur Psychiatry 1998;13:109–11.

Sachdev P . The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias. Schizophr Bull 1995;21:451–61.

Sachdev P . The epidemiology of drug-induced akathisia: Part I. Acute akathisia. Schizophr Bull 1995;21:431–19.

Lipinski JF Mallya G Zimmerman P Pope HG : Fluoxetine-induced akathisia: Clinical and theoretical implications. J Clin Psychiatry 1989;50:339–42.

Bebbington PE . Epidemiology of Obsessive-compulsive disorder. Br J Psychiatry Suppl 1998;173:2S–6S.

Bland RC Newman SC Orn H . Age of onset of psychiatric disorder. Acta Psychiatr Scand Suppl 1988;77:43S–9S.

Karno M Golding JM , Sorenson SB, and others. The epidemiology of obsessive compulsive disorder in 5 US communities. Arch Gen Psychiatry 1998;45:1094–9.

Bech P Malt UP Dencker SI Ahlfors UG Eigen K , Lewander T, and others. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993;87 Suppl 372.

Kay SR Fiszbein A Opler LA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261–76.

Montgomery SA Asberg M . A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.

First MB Spitzer RL Gibbon M Williams JEW . Structured clinical interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington (DC): American Psychiatric Press; 1997.

Elkin I Tracie Shea M Watkins IT Imber SD Sotsky SM , Collins IF, and others. National institute of mental health treatment of depression collaborative research program: General effectiveness of treatments. Arch Gen Psychiatry 1989;46:971–82.

Perruca E . A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241–56.

Zarate CA Jr Tohen M Baraibar G Kando JC Mirin J . Prescribing trends of antidepressants in bipolar depression. J Clin Psychiatry 1995;56:260–4.

Fabre LF Brodie HK Garver D Zung WW . A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients. J Clin Psychiatry 1983;44:88–94.

Humma LM Swims MP . Bupropion mimics a transient ischemic attack. Ann Pharmacother 1999;33:305–7.

Visticot F Montreuil G . Stupor encephalopathy caused by sodium valproate. Rev Med Interne 1994;15:365–6.

Larrieu JL Lagueny A Julien J . State of confusion induced by valproic acid and reversed after administration of clonazepam. Rev Electroencephalogr Neurophysiol Clin 1985;15:179–84.

Tartara A Manni R . Sodium valproate “encephalopathy”: Report of three cases with generalised epilepsy. Ital J Neurol Sei 1985;6:93–5.

Popli AP Tanquary J Lamparella V Masand PS . Bupropion and anticonvulsant drug interactions. Ann Clin Psychiatry 1995;7:99–101.

Bezchlibnyk-Butler KZ Jeffries JJ . Clinical Handbook of Psychotropic Drugs. Eighth revised edition. Toronto: Hogrefe & Huber Publishers; 1998.

Ketter TA Jenkins JB Schroeder DH Pazzaglia PJ Marangell LB , George MS, and others. Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol 1995;15:327–33.

Ascher JA Cole JO Colin JN Feighner JP Ferris RM , Fibiger HC, and others. Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395–401.

Davidson JRT Connor KM . Bupropion Sustained Release: A therapeutic overview J Clin Psychiatry 1998;59(Suppl4):25S–31S.

Glaxo Wellcome inc. Wellbutrin Monography. April 1998.

Fogelson DL Bystritsky A Pasnau R . Bupropion in the treatment of bipolar disorders: The same old story? J Clin Psychiatry 1992;53:443–6.

Frances AJ Kahn DA Carpenter D Docherty JP Donovan SL . The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998; 59(Suppl 4):73S–9S.

Canadian Network for Mood and Anxiety Treatment (C.A.N.M.A.T.) Depression Working Group. Guidelines for diagnosis and pharmacological treatment of depression. First edition. Toronto: CANMAT;1999.

Kirmayer JL Robbins JM . Three forms of somatization in primary care: Prevalence, co-ocurrence and sociodemographic caharacteristics. J Nerv Ment Dis 1991;179:647–55.

García-Campayo J Lobo A Pérez-Echeverría MJ Campos R . Three forms of somatization presenting in primary care settings in Spain. J Nerv Ment Dis 1998;186:554–60.

Craig TK Boardman AP Mills K Daly-Jones O Drake H . The South London Somatization study. I: Longitudinal course and the influence of early life experiences. Br J Psychiatry 1993;163:579–88.

Garcia-Campayo J Campos R Marco G Pérez-Echeverria MJ Lobo A . Somatization in primary care in Spain. II: Differences between somatizers and psychologizes. Br J Psychiatry 1996;168:348–53.

Kirmayer LJ Robbins JM . Patients who somatize in primary care: A longitudinal study on cognitive and social characteristics. Psychol Med 1996;26:937–51.

Verhaak PF Tijhuis MAR . The somatizing patient in general practice. Int J Psychiatry Med 1994;24:157–77.

Gardiner EA Johnston JA . Bupropion: An antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 1985;5:24–9.

Crenshaw TL Goldberg PJ . Bupropion in sexual pharmacology. In: Crenshaw TL Goldberg PJ , editors. Drugs that affect sexual functioning. New York: Norton and Co; 1996. 389–408.

Labbate LA Grimes JB Hines A Pollack MH . Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 1997;9:241–5.

Ashton AK Rosen RC . Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59:112–5.

Walker PW Cole JO Gardner EA Hughers AR Johnston JA , Batey SR, and others. Improvement in fluoxetine associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459–65.

Margolese HC Assalian P . Sexual side effects of antidepressants: A review. J Sex Marital Ther 1996;22:209–17.

Pollock BG Sweet RA Krishner M Reynold CF 3rd . Bupropion plasma levels and CYP2D6 phenotype. Ther Drug Monit 1996;18:581–5.

Spencer FA Goldberg RJ Becker RC Gore JM . Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998;31:1226–33.

Sher L . Seasonal distribution of myocardial infarction and seasonal mood changes. J Am Coll Cardiol 1999;33:2088–9.

Sher L . The possible role of seasonal mood changes in the seasonal distribution of acute myocardial infarction. Psychosomatics 1999;40:364.

Kasper S Wehr TA Bartko JJ Gaist P Rosenthal NE . Epidemiological findings of seasonal changes in mood and behavior. Arch Gen Psychiatry 1989;46:823–33.

Nemeroff CB Musselman DL Evans DL . Depression and cardiovascular disease. Depress Anxiety 1998; 8 Suppl 1:71S–9S.

Sheth T Nair C Muller I Yusuf S . Increased winter mortality from acute myocardial infarction and stroke: The effect of age. J Am Coll Cardiol 1999;33:1916–9.

Robins LN Regier DA , editors. Psychiatric disorders in America: The epidemiologic catchment area study. New York: Free Press, 1991.

Zisook S . Depression in late life. Diagnosis, course, and consequences. Postgrad Med 1996;100:143–56.

Kaplan HI Sadock BJ Grebb JA . Kaplan and Sadocks Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. 7th ed. Baltimore: William & Wilkins; 1994.

Rosenthal NE . Winter Blues: Seasonal Affective Disorder: What it is and how to overcome it. Revised, edition. New York: The Guilford Press, 1998.

Martin J Shochat T Anconi-Israel S . Illumination and depression in elderly nursing home residents. 11th annual meeting of the society for light treatment and biological rhythms: Old town Alexandria (VA); May 16–18, 1999 [abstracts].

Sher L . Elderly patients, use of antidepressants, and hip fracture. Lancet 1998;352:401.

Surawicz FG Banta R . Lycanthropy revisited. Can Psychiatr Assoc J 1975; 20:537–42.

Benezech D De Witte J , Etcheparre JJ, and others. A lycanthropic murderer. Am J Psychiatry 1989;146:942.

Verdoux H Bourgeois M . A partial form of lycanthropy with hair delusion in a manic-depressive patient. Br J Psychiatry 1993;163:684–6.

Young AW Ellis ND Szulecka TK de Pauw KW . Face processing impairments and delusional misidentification. Behavioural Neurology 1990;3:153–68.

Addington DE Toews JA Addington JM . Risperidone and tardive dyskinesia: A case report. J Clin Psychiatry 1995;56:484–5.

Woerner MG Sheitman BB Lieberman JA Kane JM . Tardive dyskinesia induced by risperidone? Am J Psychiatry 1996;153:843.

Gwinn KA Caviness JN . Risperidone-induced tardive dyskinesia and parkinsonism. Mov Disord 1997;12:119–21.

Saran BM . Risperidone-induced tardive dyskinesia. J Clin Psychiatry 1998;59: 29–30.

Sherr JD Thaker G . Progression of abnormal involuntary movements during risperidone treatment. J Clin Psychiatry 1998;59:478–9.

Woemer MG Alvir JM Saltz BL Lieberman JA Kane JM . Prospective study of tardive dyskinesia in the elderly: Rates and risk factors. Am J Psychiatry 1998; 155:1521–8.

Jeste DV Lacro JP Bailey A Rockwell E Harris MJ Caligiuri MP . Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716–9.